Cancer is driven by genetic alterations that can vary widely between different types of cancers and even among different patients with the same type of cancer. Targeted sequencing allows researchers and clinicians to focus on key genes and regions that are known to be relevant to cancer. This approach is more cost-effective and faster than whole-genome sequencing, making it a practical choice for clinical applications.
